Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Maan H. Harbi, Christopher W. Smith, Phillip L. R. Nicolson, Steve P. Watson & Mark R. Thomas. (2021) Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases. Platelets 32:1, pages 29-41.
Read now
Read now
Zhong-Guo Fan, Wen-Ling Zhang, Bing Xu, Jun Ji, Nai-Liang Tian & Sheng-Hu He. (2019) Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis. Drug Design, Development and Therapy 13, pages 719-730.
Read now
Read now
Manan Pareek, Deepak L. Bhatt, Jürrien M. Ten Berg, Steen D. Kristensen & Erik L. Grove. (2017) Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention. Expert Opinion on Pharmacotherapy 18:9, pages 875-883.
Read now
Read now
Zhong-Guo Fan, Guo-Bin Ding, Xiao-Bo Li, Xiao-Fei Gao, Ya-Li Gao & Nai-Liang Tian. (2016) The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients. Drug Design, Development and Therapy 10, pages 3435-3448.
Read now
Read now
Piotr Adamski, Urszula Adamska, Małgorzata Ostrowska, Marek Koziński & Jacek Kubica. (2016) New directions for pharmacotherapy in the treatment of acute coronary syndrome. Expert Opinion on Pharmacotherapy 17:17, pages 2291-2306.
Read now
Read now
Articles from other publishers (15)
Danny J. SoaresMDMD. (2022) Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)—Implications for Therapeutic Interventions. Molecules 27:17, pages 5398.
Crossref
Crossref
Zhong‐guo Fan, Nai‐Liang Tian, Sheng‐Hu He & Gen‐Shan Ma. (2022)
Maintained P2Y
12
inhibitor monotherapy after shorter‐duration of dual antiplatelet therapy in patients undergoing coronary drug‐eluting stents implantation: An updated meta‐analysis of randomized trials
. Journal of Clinical Pharmacy and Therapeutics 47:7, pages 860-869.
Crossref
Crossref
Oliver Buchhave Pedersen, Erik Lerkevang Grove, Steen Dalby Kristensen, Peter H. Nissen & Anne-Mette Hvas. (2021) MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease. Thrombosis and Haemostasis 122:02, pages 181-195.
Crossref
Crossref
Alexander A. Spasov, Aida F. Kucheryavenko, Ksenia A. Gaidukova, Maxim V. Chernikov & Olga N. Zhukovskaya. (2020) ANTITROMBOTIC ACTIVITY OF A NEW BENZIMIDAZOLE DERIVATIVE WITH A SPATIALLY DIFFICULT PHENOLIC SUBSTITUTE IN ITS STRUCTURE. Pharmacy & Pharmacology 8:2, pages 78-85.
Crossref
Crossref
Shijie Zhao, Zhaoshuang Zhong, Guoxian Qi, Liye Shi & Wen Tian. (2018) Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials. Clinical Drug Investigation 39:1, pages 1-13.
Crossref
Crossref
Mei-Tzu Wang, Cheng Ken Tsai, Shu-Hung Kuo, Wei-Chun Huang, Kun-Chang Lin, Wang-Ting Hung, Chin-Chang Cheng, Pei-Ling Tang, Cheng Chung Hung, Jin-Shiou Yang, Hsin-Li Liang, Guang-Yuan Mar & Chun-Peng Liu. (2018) The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study. Frontiers in Neurology 9.
Crossref
Crossref
Shengnan Wang, Junshu Jiang, Yue Wang, Qilan Jia, Shufang Dai, Yuping Wang, Li Lv & Jihong Wang. (2018) rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats. Biochemical and Biophysical Research Communications 498:1, pages 240-245.
Crossref
Crossref
E.A. Meyer, E. Caroff & M.A. Riederer. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
556
599
.
Mark R. Thomas & Robert F. Storey. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders
1015
1028
.
Kasper Adelborg, Erik Lerkevang Grove, Jens Sundbøll, Maja Laursen & Morten Schmidt. (2016) Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies. Heart 102:23, pages 1883-1889.
Crossref
Crossref
David R. Lichtenstein. (2016) When to stop, how to reverse, and when to restart antithrombotic drugs periendoscopically in nonvariceal upper gastrointestinal bleeding. Techniques in Gastrointestinal Endoscopy 18:4, pages 177-186.
Crossref
Crossref
Victor L. Serebruany, Ales Tomek, Yury Pya, Makhabbat Bekbossynova & Moo Hyun Kim. (2016) Inferiority of ticagrelor in the PHILO trial: Play of chance in East Asians or nightmare confirmation of PLATO-USA?. International Journal of Cardiology 215, pages 372-376.
Crossref
Crossref
Mohammed Jarrar, Shalini Behl, Ganiraju Manyam, Hany Ganah, Mohammed Nazir, Reem Nasab & Khaled Moustafa. (2016) Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy. Molecular Biology Reports 43:6, pages 473-484.
Crossref
Crossref
Lynn Roth, Bieke Van der Veken, Isabelle Coornaert, Wim Martinet & Guido R. Y. De Meyer. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases
140
149
.
Lynn Roth, Bieke Van der Veken, Isabelle Coornaert, Wim Martinet & Guido R. Y. De Meyer. 2016. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases
1
10
.